Followers | 13 |
Posts | 441 |
Boards Moderated | 0 |
Alias Born | 05/30/2014 |
Wednesday, January 29, 2020 1:36:52 PM
Q1 2019 revenues increased quarter over quarter from the prior year by 741% to $517,160 with a gross profit margin of 49%.
We posted an operating loss of $1.2 million for Q1 2019, which included $0.8 million in non-cash stock-based compensation.
Q2 revenues increased quarter over quarter from the prior year by 311% to $633,579 with a gross profit margin of 52.8%.
We posted an operating loss of $1,435,289 for Q2 2019, which included $959,948 in non-cash stock-based compensation.
Closed $3,936,700 cash raised subsequent to the end of the quarter in a Reg D offering.
Q3 2019 revenues increased quarter over quarter from the prior year by 277% to $615,422 with a gross margin of 77%.
We posted an operating loss of $935,264 for Q3 2019, which included $602,823 in non-cash stock-based compensation.
Key Business Highlights for 2019
Launched Pure Leaf Oil as its Consumer Brand from the acquisition of Pure Health Products LLC in December 2018.
Attained Registration in the GSA’s System for Award Management and Department of Defense.
Finalized Asset Purchase Agreement with Seven Chakras, Inc.- the Company’s Spa Line of products.
Completed a 300% increased investment in its Duramed division to combat the pain management and opioid crisis.
Conducted its Annual Shareholder Meeting on June 14 with over 200 in attendance.
Opened a new wholly-owned operating division – NY Hemp Depot LLC to develop cultivation operations under a new operating license.
The first products became available via Amazon.com.
Launched in test and development mode a dedicated Canbiola-branded CBD dispensing machine.
Approved a reverse stock split with intent to satisfy one criterion for a potential NASDAQ listing.
Launched Canbiola Turmeric & Ginger Pure Hemp Extract in 30MG capsules, Canbiola's first capsule hemp extract product.
Presented at both the H.C. Wainwright 21st Annual Global Investment Conference in September and the 12th Annual LD Micro Conference in December.
Executed an agreement for an all-stock transaction to acquire 51% of Green Grow Farms Inc. from Iconic Brands, Inc.
Also in 2019, Canbiola added key personnel including the appointment of Senator Ron Silver, James Murphy, and Alger Boyer Jr. to its Board of Directors to create an independent Board, satisfying a requirement for potential NASDAQ listing. Steven Medina Esq., Jason Winn, Dr. Mehran Peter Ghazvini, David Woycik, Jr., and John Bach joined our Corporate Advisory Board, while NFL Great Leonard Marshall joined Canbiola's Sports Advisory Board.
Canbiola, Inc. Announces 2019 Highlights and 2020 Plans for Expansion
Recent CANB News
- Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million • InvestorsHub NewsWire • 03/11/2024 12:34:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:15:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:02:41 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:38:08 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:52:26 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/08/2024 06:08:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 12:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 03:36:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 10:15:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:18:08 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/13/2023 02:44:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 06:24:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 08:57:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:12:43 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:41:28 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM